FDA approves Zykadia for NSCLC
On April 29, the U.S. Food and Drug Administration (FDA) approved Zykadia for patients with a certain type of late-stage non-small cell lung cancer…
Oncology
Make your health a priority.
May 11-17 marks National Women’s Health Week. ANA supports this effort to motivate women to make their own health a priority.
FDA approves Impavido to treat leishmaniasis
On March 19, the U.S. Food and Drug Administration (FDA) approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Read more.
Ten tips to help you reboot your nursing career
It may be time to refresh your nursing career to the latest “version.”
A powerful question: “Have you ever served in the military?”
To help ensure military veterans get appropriate diagnosis and treatment, ask patients if they’ve ever served in the military.
FDA approves Imbruvica to treat chronic lymphocytic leukemia
On Feb. 13, the U.S. Food and Drug Administration (FDA) expanded the approved use of Imbruvica (ibrutinib) for chronic lymphocytic leukemia patients who have…
Study: Radiation therapy skin reactions may be preventable
Severe skin reactions during radiation therapy could be prevented by applying a thin transparent silicone dressing to the skin from the first day of…
Study: Melanoma increases among middle-aged adults
A study in Mayo Clinic Proceedings reports that the incidence of cutaneous melanoma among middle-aged adults (40 to 60 years) has increased nearly eightfold…
The patient engagement imperative
Engaging patients is essential to ensure optimal reimbursement. Here are tips for engagement that leaders can apply in their organizations
From our readers: One nurse’s journey into patienthood
As I lay on the table staring up at the ceiling tiles and waited for my biopsy to begin, I suddenly became keenly aware…
FDA approves Mekinist in combination with Tafinlar for advanced melanoma
On Jan. 10, the U.S. Food and Drug Administration (FDA) announced it had approved Mekinist (trametinib) in combination with Tafinlar (dabrafenib) to treat patients…
FDA approves Zykadia for NSCLC
On April 29, the U.S. Food and Drug Administration (FDA) approved Zykadia for patients with a certain type of late-stage non-small cell…
Make your health a priority.
May 11-17 marks National Women’s Health Week. ANA supports this effort to motivate women to make their own health a priority.
FDA approves Impavido to treat leishmaniasis
On March 19, the U.S. Food and Drug Administration (FDA) approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Read more.
Ten tips to help you reboot your nursing career
It may be time to refresh your nursing career to the latest “version.”
A powerful question: “Have you ever served in the military?”
To help ensure military veterans get appropriate diagnosis and treatment, ask patients if they’ve ever served in the military.
FDA approves Imbruvica to treat chronic lymphocytic leukemia
On Feb. 13, the U.S. Food and Drug Administration (FDA) expanded the approved use of Imbruvica (ibrutinib) for chronic lymphocytic leukemia patients…
Study: Radiation therapy skin reactions may be preventable
Severe skin reactions during radiation therapy could be prevented by applying a thin transparent silicone dressing to the skin from the first…
Study: Melanoma increases among middle-aged adults
A study in Mayo Clinic Proceedings reports that the incidence of cutaneous melanoma among middle-aged adults (40 to 60 years) has increased…
The patient engagement imperative
Engaging patients is essential to ensure optimal reimbursement. Here are tips for engagement that leaders can apply in their organizations
From our readers: One nurse’s journey into patienthood
As I lay on the table staring up at the ceiling tiles and waited for my biopsy to begin, I suddenly became…
FDA approves Mekinist in combination with Tafinlar for advanced melanoma
On Jan. 10, the U.S. Food and Drug Administration (FDA) announced it had approved Mekinist (trametinib) in combination with Tafinlar (dabrafenib) to…
Poll
Preferred way to get content
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.